SINT - Sintx Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.7700
-0.1300 (-6.84%)
At close: 4:00PM EDT

1.7100 -0.06 (-3.39%)
Before hours: 8:18AM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Long-term KST

Long-term KST

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close1.9000
Open1.8500
Bid1.7000 x 2900
Ask1.7000 x 1200
Day's Range1.7100 - 1.8800
52 Week Range0.2800 - 4.3900
Volume2,796,232
Avg. Volume6,762,728
Market Cap30.052M
Beta (5Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    A Look Into SINTX Technologies' Price Over Earnings

    Looking into the current session, SINTX Technologies Inc. (NASDAQ: SINT) shares are trading at $2.62, after a 239.60% increase. Moreover, over the past month, the stock increased by 294.40%, but in the past year, fell by 8.93%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session.The stock is currently above from its 52 week low by 3519.86%. Assuming that all other factors are held constant, this could present itself as an opportunity for investors trying to diversify their portfolio with Medical Devices stocks, and capitalize on the lower share price observed over the year.The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.Most often, an industry will prevail in a particular phase of a business cycle, than other industries.Compared to the aggregate P/E ratio of the 0.02 in the Medical Devices industry, SINTX Technologies Inc. has a lower P/E ratio of 0.0. Shareholders might be inclined to think that they might perform worse than its industry peers. It's also possible that the stock is undervalued.P/E ratio is not always a great indicator of the company's performance. Depending on the earnings makeup of a company, investors may not be able to attain key insights from trailing earnings.See more from Benzinga * 17 Healthcare Stocks Moving In Monday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • MarketWatch

    SiNtx's stock skyrockets after upbeat data on its silicon nitride powder's effect on COVID-19 virus

    Shares of SiNtx Technologies Inc. skyrocketed more than 4-fold (up 343%) in premarket trading Monday, after the original equipment manufacturer ceramics company said the SARS-CoV-2 virus which causes COVID-19 was "inactivated" when exposed to its sintered silicon nitride powder in a controlled laboratory study. Trading volume spiked to over 847,000 shares ahead of the open, already more than half full-day average of about 1.4 million shares. The company said it will share additional data soon, once the findings are published. SiNtx said it was conducting additional testing at independent laboratories to corroborate the results. "The antiviral data are consistent with the well-established anti-bacterial properties of SINTX's silicon nitride, and with previously reported effectiveness against several single-strand RNA viruses," said Chief Executive Sonny Bal. The stock's rally comes as futures for the S&P 500 rose 0.9% ahead of the open.

  • Does Sintx Technologies, Inc. (NASDAQ:SINT) Have A Volatile Share Price?
    Simply Wall St.

    Does Sintx Technologies, Inc. (NASDAQ:SINT) Have A Volatile Share Price?

    If you're interested in Sintx Technologies, Inc. (NASDAQ:SINT), then you might want to consider its beta (a measure of...

  • Sintx Technologies (NASDAQ:SINT) Will Have To Spend Its Cash Wisely
    Simply Wall St.

    Sintx Technologies (NASDAQ:SINT) Will Have To Spend Its Cash Wisely

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For September 13, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Sintx Technologies (NASDAQ: SINT ) shares ...

  • Benzinga

    Why This Analyst Set A $3 Price Target On SINTX Shares

    The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT ) boasts five near-term catalysts that should help the stock double in value, according ...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. ACADIA Pharmaceuticals (NASDAQ: ACAD ) shares ...

  • Benzinga

    Another Case For Consistent Trading

    Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For August 16, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. NVIDIA (NASDAQ: NVDA ) shares were up 5.7% ...